Since 2013, the Canadian Donation and Transplantation Research Program (CDTRP) has supported research and innovation that addresses barriers within the fields of donation and transplantation, with the ultimate goal of advancing long-term health outcomes and quality of life for Canadian transplant patients.

Through strategic partnerships with several key partners across Canada, the CDTRP has sustained a commitment to research and development within the transplant scientific community through the continued launch of the CDTRP Research Innovation Grant Competitions. This collaborative effort between the CDTRP and our partners is intended to seed new and innovative pilot projects in the transplant and donation field.

Important dates – 2022 Competition – CLOSED

  • Competition Launch: January 11, 2022
  • Application Deadline: April 11, 2022
  • Notification Date: Mid-June 2022
  • Funding Start Date: July 2022 (upon confirmation of REB approval)
  • Study update submitted to NIC: Within 18 months of Funding Start Date
VIEW 2022 winners
VIEW PAST WINNERS
Download Terms of Reference
Since 2013, the Canadian Donation and Transplantation Research Program (CDTRP) has supported research and innovation that addresses barriers within the fields of donation and transplantation, with the ultimate goal of advancing long-term health outcomes and quality of life for Canadian transplant patients.
Through strategic partnerships with several key partners across Canada, the CDTRP has sustained a commitment to research and development within the transplant scientific community through the continued launch of the CDTRP Research Innovation Grant Competitions. This collaborative effort between the CDTRP and our partners is intended to seed new and innovative pilot projects in the transplant and donation field.
Important dates – 2022 Competition – CLOSED
  • Competition Launch: January 11, 2022
  • Application Deadline: April 11, 2022
  • Notification Date: Mid-June 2022
  • Funding Start Date: July 2022 (upon confirmation of REB approval)
  • Study update submitted to NIC: Within 18 months of Funding Start Date
VIEW PAST WINNERS
Download Terms of Reference
The Principal Applicant must:
  • Be an independent researcher working at a Canadian University or research institution
  • Be a Canadian resident, and conduct the research at a Canadian institution (study subjects may be enrolled from other countries)
  • Include an existing CDTRP Investigator as a co-applicant on the submission if the Principal Applicant is not a current CDTRP Investigator (contact CDTRP at info@cdtrp.ca if you require assistance with this)
  • Agree to integrate their study within the CDTRP structure if funded and agree to become a participating CDTRP Investigator
  • Agree to sign a Research Grant Acceptance Form with the CDTRP
  • Agree to provide progress reports, including publication plan, to the CDTRP in dissemination of study results
  • Agree to publish their work on behalf of the CDTRP and list the CDTRP as one of their author affiliations
  • Agree to acknowledge the CDTRP and relevant partner funding on any related publications arising from the study
  • If successful, agree to have their application shared in confidence with the relevant funding partner for internal documentation and auditing purposes
  • Agree that any partner funder may disclose the amount and nature of the Grant publicly on its website and in connection with any other public disclosure of payments/funding to healthcare professionals and healthcare organizations
Eligible Research Proposals

In 2022, the research proposals being considered will be those that address the One-Transplant-For-Life vision – fulfilling every donor opportunity and turning transplantation into a cure.

This funding is intended to support new/pilot projects that have not been previously funded and where this funding could help the researcher become competitive for large/national level grant funding. The research proposal must align with one of the 5 Themes of the CDTRP. 

The proposed application should describe a ‘stand alone’ project. The grant is not meant to complete funding for larger projects. The study must be completed within 18 months of receipt of funding; no renewals will be considered and extensions beyond 18 months will be considered under exceptional circumstances only. 

Non-eligible Research Proposals

The following types of proposals will not be eligible:

  • Proposals for projects that have received funding from another source, including government or industry sponsors, will not be eligible to receive a CDTRP Research Innovation Grant unless said funding is shown by the applicant to be directed to a portion of the overall project/research that is separate and distinguishable from the portion to which the proposal relates. 

  • Proposal budgets in excess of $30,000 CAD will not be considered unless there are confirmed leveraged funds from another source. 

  • Proposals for pharmaceutical product development (including studies on non-approved indications for drugs) and/or product comparison, or product promotion will not be considered. 

  • Successful applicants from the 2021 CDTRP Research Innovation Grant competition will not be considered for this competition. Applicants may submit multiple unique applications to the CDTRP Research Innovation Grant competition; however, only one award can be accepted from the CDTRP Research Innovation Grant competition per year. 

  • Investigators who have final project reports outstanding from any TRFBC competition at the application deadline will not be eligible to receive the TRFBC funded grants. 

  • Investigators who have final project reports outstanding from any KFOC competition at the application deadline will not be eligible to receive the KFOC funded grants. 

  • Grant funds may not be used for clinical training. 

For the 2022 competition, the CDTRP will offer two (2) grants at $30,000 CAD each. In addition, the CDTRP is proud to partner with the following organizations to provide funding to support up to twelve (12) grants overall:

  • Transplant Research Foundation of British Columbia (TRFBC):
    • The Venture Grants [2]
  • Kidney Foundation of Canada (KFOC) [2]
  • Alberta Transplant Institute/Paladin Labs Inc. (ATI/Paladin) [3]
  • Ontario Health (Trillium Gift of Life Network) [1]
  • University Health Network Multi-Organ Transplant Program (UHN-MOT) [1]
  • Université de Montréal (UdeM) [1]

The total value of the competition is $360,000, enough to support 12 grants of $30,000 CAD each (pending availability of partner funding).

Of the $360,000, we will support grants in the following strategic areas:

  • 2 grants of $30,000 CAD each to support new research that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These will be provided through the CDTRP Research Innovation Grant competition over an 18-month performance period with funding provided by the Canadian Donation and Transplantation Research Program. 

  • 2 grants of $30,000 CAD each to support new and innovative research primarily focused on adult and/or pediatric solid organ transplantation and donation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. Projects must include a patient, family, donor (PFD) engagement component in their design. Projects with a secondary focus on hematopoietic cell transplant must clearly outline how the intended research relates to solid organ donation or transplant research in order to be considered for this award. The Principal Applicant must hold the rank of assistant professor or higher and be based in British Columbia. The study can involve additional co-researchers, other sites and patients from across the country, provided the majority of research is conducted in British Columbia. The Transplant Research Foundation of BC/CDTRP Venture Grants will be funded by the Transplant Research Foundation of British Columbia over an 18-month performance period. 

  • 2 grants of $30,000 CAD each to support new research related to kidney donation and/or transplantation that addresses the One-Transplant-for-Life vision and aligns with one of the 5 Themes. These projects can fall under any of the four research pillars of the KFOC (biomedical, clinical, health systems, & population health). The CDTRP KFOC Research 2022 CDTRP Research Innovation Grant Competition Terms of Reference Version 1.1 – January 05, 2022 Innovation Grants will be funded by the Kidney Foundation of Canada over an 18-month performance period. 

  • The Alberta Transplant Institute (ATI) in partnership with Paladin Labs Inc. will provide three (3) additional grants of $30,000 CAD each to the top ranked unfunded Alberta-based researchers through the CDTRP ATI/Paladin Research Innovation Grant competition over an 18-month performance period. 

  • The Ontario Health (Trillium Gift of Life Network) will provide 1 additional grant of $30,000 CAD to the top ranked unfunded researcher(s) based at an Ontario Institution through the CDTRP Ontario Health (Trillium Gift of Life Network) Research Innovation Grant competition over an 18-month performance period. Only proposals pertaining to organ donation and/or transplantation, and/or organ donor registration will be considered. 

  • The UHN-MOT will provide 1 additional grants of $30,000 CAD each to the top ranked unfunded UHN researchers through the CDTRP UHN Research Innovation Grant competition over an 18-month performance period. 

  • The Université de Montréal will provide 1 additional grant of $30,000 CAD to the top ranked unfunded UdeM researcher through the CDTRP UdeM Research Innovation Grant competition over an 18-month performance period.

Each grant will be awarded to the successful applicant(s) via the Primary Applicant’s institution.

Three-page Proposal and Figures/Tables: 
  • The research proposal should be novel, previously unpublished and not exceed 3 pages (not including references), with a maximum of 3 additional pages for figures or tables. 
  • Suggested headings include 1) Statement of Objective(s), 2) Recent relevant research by applicant, 3) Brief review of literature and background information, 4) Hypothesis(es), 5) Design and Methodology, 6) Analysis of Data, 7) Anticipated Timeline, and 8) Impact, Future research plans and Knowledge Translation. 
In addition to the 3-page proposal, the application must include:
  • The contact information requested in the application form, including the optional EDI questions. This page will be removed from your application prior to review. 

  • Please note that a letter of collaboration from a CDTRP co-application is required if the principal applicant is not an investigator in the CDTRP. 

  • The names of individuals that should NOT review your application, with justification. 

  • A half-page summary of the research proposal that highlights how the research proposal helps achieve the One-Transplant-for-Life vision to fulfill every donation opportunity and turn transplantation into a cure. This summary will be used by the NIC and shared with funding partners to assess the relevance of the application to the scope of the competition. (max ½ page) 

  • lay abstract (max 250 words) that can be used to explain the proposal to PFD reviewers and the general public and that could be posted publicly if funded. This abstract should be free of jargon, technical or undefined scientific terms, and written in a manner that is easily understood by someone without prior knowledge of the subject. To help you with the lay abstract, you can use this tool: https://hemingwayapp.com/.

  • References (no page limit) 

  • A one page description of the budget and justification. 

  • A separate description of how the proposal will integrate within a specific Theme of the CDTRP (max ½ page). We encourage you to contact the Lead or Manager of that Theme to get advice and suggestions on how to best integrate your project (https://cdtrp.ca/en/research/) – a support letter from the Lead is not required. 

  • An explanation of how sex, as a biological variable, gender, as a socio-cultural factor, and diversity are taken into account in the research design, methods, analysis and interpretation, and/or dissemination of findings, or explain why they are not relevant/feasible within the scope of the project. For guidance and resources on how to integrate sex and gender into research, please consult the CIHR website. (max ½ page). 

  • For CDTRP, engaging patients, families, and donors in research is a core value. Describe how this project supports patient, family or donor priorities. If you have a PFD Engagement Plan for your project, please include it (max 1 page). The engagement plan should include a description of the key roles and responsibilities envisioned for PFD partners and how your research will benefit from PFD engagement. If you believe this project could benefit from enhanced PFD engagement, outline how you would like CDTRP to support this work. Note that PFD Partnership Platform Manager Manuel Escoto (mescoto@cdtrp.ca) would be pleased to provide support as you are developing your project. Note: PFD remuneration ($50/hr) is an eligible grant expense. For more information on the CDTRP PFD platform, please visit our website: CDTRP PFD Partnership platform. All applications for TRFBC grants must include a PFD Engagement Plan. 

  • A copy of a CIHR BioSketch Common CV for the Principal Applicant. 

  • Optional: Applicants may also include letters of support and/or commitment from the Chair of the Department/Division indicating the level of institutional and/or university support. 

The completed application must be submit electronically (by using the link) no later than 11:59pm PST on April 11, 2022. The magnitude of the project should match the size of the award; the award is not intended to supplement a major grant; however, it is anticipated that this funding will be used to produce data to apply for large/national level grant funding. 

Documentation received after the submission deadline will not be submitted for review. The applicant is responsible for ensuring completeness of the application and incomplete or unsigned applications will not be considered. Applicants must submit their application electronically using this link.

Suggested headings for the research proposal include 1) Statement of Objective(s), 2) Recent relevant research by applicant, 3) Brief review of literature and background information, 4) Hypothesis(es), 5) Design and Methodology, 6) Analysis of Data, 7) Anticipated Timeline, and 8) Impact, Future research plans and Knowledge Translation. The applicant must use Calibri or Arial font, size 12 points or larger. Use at least 2 cm (3/4 inch) margins (top, bottom, left, and right) for all pages. The section name and the name of the Principal Applicant should appear in the header. 

Who can apply to the Innovation Grant competition?

The Principal Applicant must be a CDTRP Investigator or include an existing CDTRP Investigator as a co-applicant on the submission. To accept the award, the Principal Applicant is to become a member. If you are not sure whether you are a current member, contact us at info@cdtrp.ca. 

Will the CDTRP write me a letter of support for my application?

A letter from the CDTRP is unnecessary: for this competition, we have the role of a funding agency.  

Can the funds from these grants be used to purchase equipment?

The Innovation Grant competition is a “research” grant and not an “equipment” grant, and so the application should really be focused on research activities and outcomes.  However, if you need new equipment to do the research, it is an allowable expense.  

Is there a limit on the number of co-applicants?

There is no limit for the number of co-applicants.

How can I integrate my project into the CDTRP?

Here are some ways to integrate a project into the CDTRP network: 

  • Register any trainees working on the project with the CDTRP Education and Training platform;
  • Connect with Manuel Escoto (mescoto@cdtrp.ca) ensure the patient engagement plan is strong and for support to identify patient partners;
  • Post plain language project outputs on the CDTRP Patient Portal;
  • Present your project at a CDTRP Theme Meeting – especially helpful if you are seeking collaborations with other Theme members.
How can I prepare my patient engagement plan?

Engaging patients, families, and donors (PFD) partners is a core value for CDTRP. As you prepare your Innovation Grant Application, use these resources to develop your PFD Engagement Plan.